Improving Supportive Care For Patients With Thoracic Malignancies

Study summary

The purpose of this study is to use a proactive approach to improve symptom management of patients with thoracic malignancies and ensure receipt of evidence-based cancer care delivery. In this pilot study, the investigators propose to evaluate the feasibility of using outbound, proactive telephone symptom assessment strategies and ensuring evidence-based care receipt and measure the efficacy of this approach on patient satisfaction with their care, patient activation, quality of life and use of healthcare resources.

Ask AI to explain this study

Start here

Key things to know

Main goalSupportive Care

This describes the study’s primary purpose.

What is being studiedWeekly telephone symptom assessment

The study team can explain what participation involves.

Who it may be forLung Cancer · Quality of Life

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated Mar 21, 2024 · Source: ClinicalTrials.gov

Is enrollment open?Completed

Ask the study team to confirm whether enrollment is open.

What kind of study?Not applicable

Interventional

Where is it offered?1 U.S. location

Locations may change over time.

Who runs it?Palo Alto Veterans Institute for Research

Study sponsor

Study overview

What this study is about

Purpose: Supportive Care
Study type: Interventional
Phase: Not applicable
Sponsor: Palo Alto Veterans Institute for Research
Interventions being studied: Behavioral: Weekly telephone symptom assessment

Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

Treatment approach

Supportive or behavioral care→

Study topics

Survivorship and quality of life→

Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria

All patients with lung cancer treated at VA Palo Alto. This includes all newly diagnosed patients and those under follow-up care.

Reasons someone may not be able to joinExclusion criteria

Patients who do not anticipate receiving oncology care at the VA Palo Alto Health Care System.
Patients who are unable to consent.

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

Study sites

U.S. locations

VA Palo Alto Health Care SystemPalo Alto, California

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Mar 21, 2024. Always confirm current availability with the study team.

View original record ↗